Press/Media
- 625 - 650 out of 2,668 results
Search results
-
health expert Now accepting submissions. health issues at the forefront
Deborah Marshall & Deborah Marshall
9/02/23
1 item of Media coverage
Press/Media
-
Studies from Tongji University Describe New Findings in Drug Research (Native and Engineered Exosomes for Inflammatory Disease)
9/02/23
1 item of Media coverage
Press/Media
-
Mesoblast (MSB: $A1.20) - PRE-MARKET CONFIRMATORY BULLISH SIGNAL FROM ITS ADR MARKET Thursday February 09, 2023 08:02 AEDT
8/02/23
1 item of Media coverage
Press/Media
-
Mesoblast (MSB: $A1.20) hits eleven-month high on average volume
8/02/23
1 item of Media coverage
Press/Media
-
-
Weekly: Mesoblast (MSB: $A1.04) in top 3% performers of All Ordinaries Index in past week; +10c [10.6%]
7/02/23
1 item of Media coverage
Press/Media
-
Stuff to Watch: Your guide to the week's best on Sky and free-to-air TV
6/02/23 → 7/02/23
7 items of Media coverage
Press/Media
-
-
Mesoblast (MSB: $A1.16) closes at 16% above VWAP, hits 64-day high
7/02/23
1 item of Media coverage
Press/Media
-
Mesoblast (MSB: $A1.16) - PRE-MARKET CONFIRMATORY BULLISH SIGNAL FROM ITS ADR MARKET Wednesday February 08, 2023 08:02 AEDT
7/02/23
1 item of Media coverage
Press/Media
-
Mesoblast (MSB: $A1.14) - PRE-MARKET CONFIRMATORY BULLISH SIGNAL FROM ITS ADR MARKET Tuesday February 07, 2023 08:02 AEDT
6/02/23
1 item of Media coverage
Press/Media
-
Stuff to Watch: Your guide to the week's best on Sky and free-to-air TV
6/02/23
1 item of Media coverage
Press/Media
-
-
Weekly: Mesoblast (MSB: $A1.04) in top 3% performers of All Ordinaries Index in past week; +10c [10.6%]
4/02/23
1 item of Media coverage
Press/Media
-
-
Mesoblast (MSB: $A1.04) - PRE-MARKET CONFIRMATORY BULLISH SIGNAL FROM ITS ADR MARKET Monday February 06, 2023 08:02 AEDT
3/02/23
1 item of Media coverage
Press/Media
-
-
Ningbo University Reports Findings in Kawasaki Disease (Plasma interleukin-41 serves as a potential diagnostic biomarker for Kawasaki disease)
2/02/23
1 item of Media coverage
Press/Media
-